SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-14-275614
Filing Date
2014-07-22
Accepted
2014-07-22 16:40:06
Documents
15

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS FILED PURSUANT TO 424(B)(4) d704577d424b4.htm 424B4 1417168
2 GRAPHIC g704577g09k06.jpg GRAPHIC 51203
3 GRAPHIC g704577g31a53.jpg GRAPHIC 40192
4 GRAPHIC g704577g36n94.jpg GRAPHIC 35502
5 GRAPHIC g704577g42h18.jpg GRAPHIC 73873
6 GRAPHIC g704577g51w67.jpg GRAPHIC 50601
7 GRAPHIC g704577g55m39.jpg GRAPHIC 33345
8 GRAPHIC g704577g59b89.jpg GRAPHIC 36715
9 GRAPHIC g704577g64l82.jpg GRAPHIC 62964
10 GRAPHIC g704577g67a41.jpg GRAPHIC 44592
11 GRAPHIC g704577g73a92.jpg GRAPHIC 25606
12 GRAPHIC g704577g74m10.jpg GRAPHIC 36815
13 GRAPHIC g704577g75k85.jpg GRAPHIC 36180
14 GRAPHIC g704577g89g88.jpg GRAPHIC 30205
15 GRAPHIC g704577g98h56.jpg GRAPHIC 39490
  Complete submission text file 0001193125-14-275614.txt   2243348
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-195127 | Film No.: 14986969
SIC: 2834 Pharmaceutical Preparations